We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Researchers Pursue Single-dose Gene Therapy for Cocaine Addiction

News   Jan 08, 2020 | Original story from Mary Ann Liebert, Inc.

 
Researchers Pursue Single-dose Gene Therapy for Cocaine Addiction

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Increase in Genome-Editing Trials Means Change for Informed Consent Process

News

Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, asked patients, parents and physicians in the sickle cell disease community what they wanted and needed to know about genome editing to make informed decisions about participating in genome-editing clinical trials.

READ MORE

Neoantigens Could Be Key to Unlocking a New Generation of Immunotherapies

News

Scientists have discovered parameters to better predict which neoantigens can stimulate a cancer-killing effect.

READ MORE

OncoHost Data on Host Immunotherapy Response to be Presented This Week

News

OncoHost, announced that Professor Yuval Shaked, Professor of Cell Biology and Cancer Science at the Technion – Israel Institute of Technology, will deliver a presentation titled A Proteomics-Based Platform for Predicting Response to Immunotherapy and Personalizing Treatment Plans at the MAP 2020 Virtual Congress.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE